Marshall Wace Asia’s Intuitive Surgical ISRG Stock Holding History

Marshall Wace Asia’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,641	Closed	-$3.74M	–	123
2019 Q1	$3.74M	Buy	+19,641	New	+$3.49M	0.11%	68

Other funds holding ISRG

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Marshall Wace Asia's ISRG Position: Q2 2019 in Review

Marshall Wace Asia sold out of Intuitive Surgical (ISRG) in Q2 2019, closing a stake of 19,641 shares — an estimated $3.74M sold.

Marshall Wace Asia first reported a position in ISRG in Q1 2019 and held it in 1 quarter. The position peaked at $3.74M in Q1 2019. 915 funds tracked by Wall St. Rank hold ISRG as of Q2 2019.

Marshall Wace Asia reported no remaining Intuitive Surgical position as of Q2 2019 after selling out during the quarter.
Marshall Wace Asia sold 19,641 Intuitive Surgical shares in Q2 2019, an estimated $3.74M.
Marshall Wace Asia first reported a position in Intuitive Surgical in Q1 2019 and held it in 1 quarter.
Marshall Wace Asia's Intuitive Surgical position peaked at $3.74M in Q1 2019.
915 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2019.

Based on Marshall Wace Asia's 13F filing for Q2 2019, filed 14 Aug 2019.